Hae-Ki Min Selected Research

25-hydroxycholesterol 3-sulfate

1/2017	Cholesterol metabolites alleviate injured liver function and decrease mortality in an LPS-induced mouse model.
3/2013	5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hae-Ki Min Research Topics

Disease

13	Non-alcoholic Fatty Liver Disease 12/2022 - 12/2009
3	Inflammation (Inflammations) 01/2018 - 03/2013
2	Fibrosis (Cirrhosis) 12/2022 - 01/2018
2	Fatty Liver 01/2021 - 12/2017
2	Obesity 01/2016 - 01/2016
2	Insulin Resistance 01/2016 - 03/2013
1	Disease Progression 12/2022
1	Edema (Dropsy) 12/2017
1	Jaundice (Icterus) 12/2017
1	Gonorrhea 12/2017
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2017
1	Multiple Organ Failure (MODS) 01/2017
1	Hypertriglyceridemia 01/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015
1	Liver Diseases (Liver Disease) 07/2014
1	Hepatocellular Carcinoma (Hepatoma) 07/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2014
1	Infections 01/2014
1	Anaphylaxis (Anaphylactic Shock) 06/2004
1	Systemic Mastocytosis 06/2004

Drug/Important Bio-Agent (IBA)

4	LipidsIBA 12/2017 - 12/2009
2	Bile Acids and Salts (Bile Acids)IBA 12/2022 - 01/2018
2	SugarsIBA 01/2021 - 12/2017
2	25-hydroxycholesterol 3-sulfateIBA 01/2017 - 03/2013
2	MicroRNAs (MicroRNA)IBA 01/2016 - 05/2012
2	LDL CholesterolIBA 01/2016 - 05/2012
2	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2015 - 05/2012
2	Triglycerides (Triacylglycerol)IBA 07/2014 - 05/2012
2	OxysterolsIBA 01/2014 - 03/2013
2	CholesterolIBA 01/2014 - 05/2012
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 12/2022
1	AcidsIBA 12/2022
1	16S Ribosomal RNAIBA 12/2022
1	Dehydrocholic Acid (Sodium Dehydrocholate)IBA 12/2022
1	choloylglycine hydrolaseIBA 12/2022
1	Glycodeoxycholic AcidIBA 12/2022
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	Hydroxysteroid DehydrogenasesIBA 12/2022
1	Drinking WaterIBA 01/2021
1	LuciferasesIBA 01/2021
1	Phospholipases (Phospholipase)IBA 01/2021
1	Glycocholic AcidIBA 01/2018
1	Chenodeoxycholic Acid (Chenix)FDA Link 01/2018
1	CholatesIBA 01/2018
1	Taurolithocholic AcidIBA 01/2018
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2018
1	manassantin AIBA 12/2017
1	Prothrombin (Factor II)IBA 12/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2017
1	Interleukin-8 (Interleukin 8)IBA 12/2016
1	Insulin-Like Growth Factor Binding Protein 3IBA 12/2016
1	DiamondIBA 01/2016
1	EicosanoidsIBA 01/2016
1	Cytokine Receptors (Cytokine Receptor)IBA 05/2015
1	ElementsIBA 05/2015
1	Peptides (Polypeptides)IBA 01/2015
1	MethyltransferasesIBA 01/2015
1	Methionine (L-Methionine)FDA Link 01/2015
1	HomocysteineIBA 01/2015
1	Caspase 3 (Caspase-3)IBA 01/2015
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 07/2014
1	Proteins (Proteins, Gene)FDA Link 07/2014
1	Sterol Regulatory Element Binding Protein 1IBA 03/2013
1	Interleukin-1 (Interleukin 1)IBA 03/2013
1	Messenger RNA (mRNA)IBA 03/2013
1	Insulin (Novolin)FDA Link 03/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013
1	Glucose (Dextrose)FDA LinkGeneric 03/2013
1	LDL Receptors (LDL Receptor)IBA 05/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2012
1	Cholesterol Esters (Cholesteryl Esters)IBA 05/2012
1	Adenylate KinaseIBA 05/2012
1	palmitoleic acidIBA 12/2009
1	Palmitic Acid (Hexadecanoic Acid)IBA 12/2009
1	Oleic Acid (Oleate)IBA 12/2009
1	Tryptases (Tryptase)IBA 06/2004

Therapy/Procedure

2	Therapeutics 12/2022 - 01/2017
1	Traditional Medicine (Folk Remedies) 12/2017
1	Intravenous Injections 01/2017